GlaxoSmithKline Pharmaceuticals net profit for the fourth quarter ended December 31, 2009 halved to Rs 103.6 crore from Rs 208.4 crore in the corresponding quarter last year.
Revenue for the quarter at Rs 449.9 crore increased 19.8 per cent from Rs 375.5 crore registered in the same quarter last year.
The Group’s net profit for the year ended December 31, 2009 was down 14 per cent at Rs 507.8 crore from Rs 591 crore reported last year. Revenue for the full year at Rs 1,926.5 crore was up 10.6 per cent from Rs 1,742.6 crore for the year ended December 31, 2008.
The company also announced the payment of dividend of Rs 30 per share for the year ended December 31, 2009.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app